L1CAM and endometrioid adenocarcinoma: The authors found 10% L1CAM expression in stage I endometrioid adenocarcinomas, 18% in 160 advanced-stage endometrioid adenocarcinomas, and 75% expression in non-endometrioid carcinomas [46].